Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Press

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
Blood|January 7, 2009
A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinationsJohn M Pagel, Nural Orgun, Donald K Hamlin, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
High-dose radioimmunotherapy of B cell lymphomasO W Press, J F Eary, C C Badger, et al.
Haematologica|January 25, 2012
Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy aloneDaniel O Persky, David Dornan, Bryan H Goldman, et al.
Cancer Research|February 1, 1990
High dose radiolabeled antibody therapy of lymphomaI D Bernstein, J F Eary, C C Badger, et al.
Bone Marrow Transplantation|October 11, 2001
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimensF Gutierrez-Delgado, D G Maloney, O W Press, et al.
Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Medical Physics|July 1, 1994
Post therapy imaging in high dose I-131 radioimmunotherapy patientsJ F Eary, K R Pollard, L D Durack, et al.
Leukemia & Lymphoma|October 6, 2007
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantationGrant E Keeney, Ted A Gooley, Rosalyn N Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenograftsKrishnan Subbiah, Don K Hamlin, John M Pagel, et al.
Bone Marrow Transplantation|January 1, 1992
Is there a better way to deliver total body irradiation?F R Appelbaum, C C Badger, I D Bernstein, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
Blood|January 7, 2009
A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinationsJohn M Pagel, Nural Orgun, Donald K Hamlin, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
High-dose radioimmunotherapy of B cell lymphomasO W Press, J F Eary, C C Badger, et al.
Haematologica|January 25, 2012
Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy aloneDaniel O Persky, David Dornan, Bryan H Goldman, et al.
Cancer Research|February 1, 1990
High dose radiolabeled antibody therapy of lymphomaI D Bernstein, J F Eary, C C Badger, et al.
Bone Marrow Transplantation|October 11, 2001
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimensF Gutierrez-Delgado, D G Maloney, O W Press, et al.
Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Medical Physics|July 1, 1994
Post therapy imaging in high dose I-131 radioimmunotherapy patientsJ F Eary, K R Pollard, L D Durack, et al.
Leukemia & Lymphoma|October 6, 2007
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantationGrant E Keeney, Ted A Gooley, Rosalyn N Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenograftsKrishnan Subbiah, Don K Hamlin, John M Pagel, et al.
Bone Marrow Transplantation|January 1, 1992
Is there a better way to deliver total body irradiation?F R Appelbaum, C C Badger, I D Bernstein, et al.
Pageof 28